Cargando…

Targeted Anticancer Immunotoxins and Cytotoxic Agents with Direct Killing Moieties

Despite the progress of the bioinformatics approach to characterize cell-surface antigens and receptors on tumor cells, it remains difficult to generate novel cancer vaccines or neutralizing monoclonal antibody therapeutics. Among targeted cancer therapeutics, biologicals with targetable antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawakami, Koji, Nakajima, Oumi, Morishita, Ryuichi, Nagai, Ryozo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2006
Materias:	Mini-Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917189/ https://www.ncbi.nlm.nih.gov/pubmed/16830050 http://dx.doi.org/10.1100/tsw.2006.162

Ejemplares similares

Evaluation of Hydra HALT-1 as a toxin moiety for recombinant immunotoxin
por: Jiemy, William F., et al.
Publicado: (2020)

Modular Pore-Forming Immunotoxins with Caged Cytotoxicity Tailored by Directed Evolution
por: Mutter, Natalie L., et al.
Publicado: (2018)

Abrin Immunotoxin: Targeted Cytotoxicity and Intracellular Trafficking Pathway
por: Gadadhar, Sudarshan, et al.
Publicado: (2013)

Efficiency of Immunotoxin Cytotoxicity Is Modulated by the Intracellular Itinerary
por: Tortorella, Lori L., et al.
Publicado: (2012)

Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.
por: Flavell, D. J., et al.
Publicado: (1997)

Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation
por: Martinez de Pinillos Bayona, Alejandra, et al.
Publicado: (2016)

Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components
por: Dosio, Franco, et al.
Publicado: (2011)

Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain
Publicado: (1984)

Spheroids of HER2-Positive Breast Adenocarcinoma for Studying Anticancer Immunotoxins In Vitro
por: Balalaeva, I. V., et al.
Publicado: (2017)

Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH
por: Liu, Xiaoyu, et al.
Publicado: (2023)

Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents
por: Çalışkan, Burcu, et al.
Publicado: (2018)

Synthesis, and docking studies of novel heterocycles incorporating the indazolylthiazole moiety as antimicrobial and anticancer agents
por: Dawoud, Nadia T. A., et al.
Publicado: (2022)

Tea Polyphenols Regulate Key Mediators on Inflammatory Cardiovascular Diseases
por: Suzuki, Jun-ichi, et al.
Publicado: (2009)

Nucleic Acid Drugs for Prevention of Cardiac Rejection
por: Suzuki, Jun-ichi, et al.
Publicado: (2009)

Design, Synthesis and Cytotoxic Activity Evaluation of Newly Synthesized Amides-Based TMP Moiety as Potential Anticancer Agents over HepG2 Cells
por: Al-Warhi, Tarfah, et al.
Publicado: (2022)

Synergistic Anticancer Effects of the 9.2.27PE Immunotoxin and ABT-737 in Melanoma
por: Risberg, Karianne, et al.
Publicado: (2011)

Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity
por: Mazor, Ronit, et al.
Publicado: (2016)

Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent
por: Horibe, Tomohisa, et al.
Publicado: (2011)

Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents
por: Al-Majid, Abdullah Mohammed, et al.
Publicado: (2021)

The Synthesis of Conjugated Peptides Containing Triazole and Quinolone-3-Carboxamide Moieties Designed as Anticancer Agents
por: Esfandiari Mazandaran, Kiana, et al.
Publicado: (2021)

Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents
por: Afzal, Obaid, et al.
Publicado: (2022)

The ubiquitin-proteasome system: A novel target for anticancer and anti-inflammatory drug research
por: Ostrowska, Halina
Publicado: (2008)

Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents
por: Asrorov, Akmal M., et al.
Publicado: (2022)

Immunotoxins: experimental design
por: Dall, P, et al.
Publicado: (2001)

Immunotoxins: The Role of the Toxin (†)
por: Antignani, Antonella, et al.
Publicado: (2013)

Countering immunotoxin immunogenicity
por: Flavell, David J
Publicado: (2016)

Recognition and killing of tumour cells expressing heat shock protein 65 kD with immunotoxins containing saporin.
por: Poccia, F., et al.
Publicado: (1992)

Recombinant immunotoxin targeting GPC3 is cytotoxic to H446 small cell lung cancer cells
por: Rodakowska, Ewelina, et al.
Publicado: (2021)

Anatomical Targeting of Anticancer Drugs to Solid Tumors Using Specific Administration Routes: Review
por: Saito, Akira, et al.
Publicado: (2023)

Anticancer Agents as Design Archetypes: Insights into the Structure–Property Relationships of Ionic Liquids with a Triarylmethyl Moiety
por: Anderson, Grace I., et al.
Publicado: (2022)

Diverse microtubule-targeted anticancer agents kill cells by inducing chromosome missegregation on multipolar spindles
por: Zhou, Amber S., et al.
Publicado: (2023)

Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy
por: Bokori-Brown, Monika, et al.
Publicado: (2018)

Panbinostat decreases cFLIP and enhances killing of cancer cells by immunotoxin LMB-100 by stimulating the extrinsic apoptotic pathway
por: Liu, Xiu-Fen, et al.
Publicado: (2017)

Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells
por: Polito, Letizia, et al.
Publicado: (2017)

Clinical targeting recombinant immunotoxins for cancer therapy
por: Li, Meng, et al.
Publicado: (2017)

Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
por: Hagerty, Brendan L., et al.
Publicado: (2020)

Novel Phthalazin-1(2H)-One Derivatives Displaying a Dithiocarbamate Moiety as Potential Anticancer Agents
por: Vila, Noemí, et al.
Publicado: (2022)

Treatment of solid tumors with immunotoxins
por: Messmer, Davorka, et al.
Publicado: (2005)

Bouganin, an Attractive Weapon for Immunotoxins
por: Bortolotti, Massimo, et al.
Publicado: (2018)

Immunotoxin Therapy for Lung Cancer
por: Xie, Li-Yi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_poigquc5mdfd8m6darpe7ip08l